SpectraScience (US) collaborates with Massachusetts General Hospital
This article was originally published in Clinica
Executive Summary
SpectraScience (US) and Massachusetts General Hospital have entered a two-year collaboration for the spectroscopic detection of cancer using minimally-invasive techniques. The clinical research agreement aims to identify and differentiate pre-cancerous lesions and cancerous tissues.